These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8793598)

  • 1. Pharmacokinetics and drug interactions--relevant factors for the choice of a drug.
    Zech K; Steinijans VW; Huber R; Kolassa N; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S3-6. PubMed ID: 8793598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S31-50. PubMed ID: 8793602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration.
    Bliesath H; Huber R; Hartmann M; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S18-24. PubMed ID: 8793600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of pantoprazole drug interactions in man.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):385-99. PubMed ID: 7981922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics--a relevant factor for the choice of a drug?
    Benet LZ; Zech K
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():25-32. PubMed ID: 8180291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S7-16. PubMed ID: 8793599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
    Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):243-62. PubMed ID: 8793611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration.
    Bliesath H; Huber R; Hartmann M; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):44-50. PubMed ID: 8199751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole (Protonix).
    Med Lett Drugs Ther; 2000 Jul; 42(1083):65-6. PubMed ID: 10908422
    [No Abstract]   [Full Text] [Related]  

  • 13. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S81-5. PubMed ID: 8793608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction as an equivalence problem.
    Steinijans VW; Hartmann M; Huber R; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S25-30. PubMed ID: 8793601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proton pump inhibitors: Pantoprazole].
    Takeuchi K; Hase S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():655-60. PubMed ID: 11979865
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S76-80. PubMed ID: 8793607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
    Shin JM; Sachs G
    Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pantoprazole lacks induction of CYP1A2 activity in man.
    Hartmann M; Zech K; Bliesath H; Steinijans VW; Koch H; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1999 Apr; 37(4):159-64. PubMed ID: 10235417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers.
    Tanaka M; Yamazaki H; Ryokawa Y; Hakusui H; Nakamichi N; Sekino H
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):415-9. PubMed ID: 8897077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):481-5. PubMed ID: 8520804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.